Capricor Therapeutics, Inc.
Industry
- Pharmaceuticals
- Biotechnology
- Large Molecule
- Gene Therapy, Cell Therapy
Other Names/Subsidiaries
- Capricor
- Nile Therapeutics
Latest on Capricor Therapeutics, Inc.
Top cell and gene therapy regulators Nicole Verdun and her deputy Rachael Anatol were forced out of the US Food and Drug Administration June 18, per multiple sources familiar with the matter. A commen
The US Food and Drug Administration’s July advisory committee schedule includes a curious mix of vaccine safety reviews and the potentially triumphant return of a pulled multiple myeloma drug, in addi
The regenerative medicine sector continues to seek increased contact with the US Food and Drug Administration, even as the architects of the Center for Biologics Evaluation and Research review structu
The US Food and Drug Administration heard mixed messages about what, if any, findings from two opioid analgesic product postmarketing studies should be included in labeling or communicated to patients